Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Thromb Res. 2016 Feb 1;140:110–117. doi: 10.1016/j.thromres.2016.01.026

Figure 6. Platelet activation in DeBakey VAD 2h post-in vivo ASA treatment.

Figure 6

a) PAS was measured for 1000 mg ASA-treated platelets and untreated platelets recirculated for 30 min through the VAD, with b) PAR determined from the slope of lines fit to PAS values (n = 7, p < 0.001).